BRUNI, Alessio
 Distribuzione geografica
Continente #
AS - Asia 2.826
NA - Nord America 2.147
EU - Europa 912
SA - Sud America 487
AF - Africa 37
OC - Oceania 4
Totale 6.413
Nazione #
US - Stati Uniti d'America 2.069
CN - Cina 1.155
SG - Singapore 814
BR - Brasile 386
IT - Italia 343
HK - Hong Kong 284
VN - Vietnam 253
GB - Regno Unito 154
KR - Corea 149
SE - Svezia 83
DE - Germania 79
RU - Federazione Russa 42
ID - Indonesia 41
AR - Argentina 40
UA - Ucraina 40
MX - Messico 34
FI - Finlandia 33
TR - Turchia 29
CA - Canada 26
BD - Bangladesh 23
BG - Bulgaria 21
BE - Belgio 19
FR - Francia 18
IN - India 17
NL - Olanda 16
EC - Ecuador 15
PL - Polonia 15
CO - Colombia 14
ES - Italia 14
JP - Giappone 12
ZA - Sudafrica 12
VE - Venezuela 9
IQ - Iraq 8
PY - Paraguay 8
CL - Cile 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
PK - Pakistan 6
RO - Romania 6
PE - Perù 5
BZ - Belize 4
DZ - Algeria 4
IE - Irlanda 4
IR - Iran 4
TN - Tunisia 4
AL - Albania 3
AT - Austria 3
AU - Australia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
KE - Kenya 3
RS - Serbia 3
UZ - Uzbekistan 3
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JM - Giamaica 2
KZ - Kazakistan 2
MA - Marocco 2
NP - Nepal 2
QA - Qatar 2
SI - Slovenia 2
TG - Togo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AD - Andorra 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
IL - Israele 1
JO - Giordania 1
MK - Macedonia 1
MU - Mauritius 1
MW - Malawi 1
NA - Namibia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 6.413
Città #
Hefei 779
Singapore 465
Ashburn 304
Hong Kong 277
Santa Clara 217
Fairfield 211
Seoul 149
Ho Chi Minh City 89
Houston 85
Los Angeles 80
Chandler 76
Woodbridge 76
Wilmington 74
Seattle 71
London 67
Cambridge 61
Shanghai 61
Beijing 60
Hanoi 55
Modena 49
Kent 46
Southend 41
Buffalo 40
Chicago 38
Nyköping 38
Dallas 32
São Paulo 32
Ann Arbor 25
Council Bluffs 24
Mexico City 24
Milan 24
Helsinki 22
Jakarta 22
Princeton 21
Dearborn 20
Salt Lake City 20
Rome 19
San Diego 19
New York 18
Sofia 18
Boardman 16
The Dalles 16
Warsaw 15
Jacksonville 14
Leuven 14
Munich 14
Montreal 12
Turin 12
Brooklyn 11
Denver 11
Eugene 11
Lappeenranta 11
Poplar 11
Reggio Emilia 11
Tokyo 11
Biên Hòa 10
Izmir 10
Johannesburg 10
Lauterbourg 10
Rio de Janeiro 10
San Jose 10
Curitiba 9
Da Nang 9
Elk Grove Village 9
Frankfurt am Main 9
Las Vegas 9
Moscow 9
Nuremberg 9
Portsmouth 9
Tampa 9
Ankara 8
Bologna 8
Brasília 8
Dhaka 8
Orem 8
Osasco 8
Florence 7
Haiphong 7
Phoenix 7
Thái Nguyên 7
Bremen 6
Falkenstein 6
Guarulhos 6
Istanbul 6
Porto Alegre 6
San Francisco 6
Timisoara 6
Verona 6
Albuquerque 5
Asunción 5
Atlanta 5
Belo Horizonte 5
Boston 5
Buenos Aires 5
Bình Dương 5
Düsseldorf 5
Guangzhou 5
Naples 5
Ninh Bình 5
Quito 5
Totale 4.364
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 256
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 253
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study 235
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 197
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 165
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 160
SIS epidemiological model for adaptive RT: Forecasting the parotid glands shrinkage during tomotherapy treatment 155
Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy? 145
Pineoblastoma in Adults: A Rare Case Successfully Treated with Multimodal Approach Including Craniospinal Irradiation Using Helical Tomotherapy 143
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC 124
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 119
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study 117
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 110
Evaluation of the effectiveness of novel single-intervention adaptive radiotherapy strategies based on daily dose accumulation 110
Oligorecurrent Non-Small-Cell Lung Cancer Treated by Chemo-Radiation Followed by Immunotherapy and Intracranial Radiosurgery: A Case Report and Mini Review of Literature 110
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis 106
Quality of life after prostate cancer diagnosis: Data from the Pros-IT CNR 99
Erratum: The role of postoperative radiotherapy for thymomas: A multicentric retrospective evaluation from three Italian centers and review of the literature (Journal of Thoracic Disease (2020) 12 (7518-7530) DOI: 10.21037/jtd-2019-thym-09) 97
The role of postoperative radiotherapy for thymomas: a multicentric retrosepective evaluation from three Italian centers and review of the literature. 94
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 93
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative “triplet” for oligometastatic hormone sensitive prostate cancer patients 92
Response to Letter to the Editor Titled “Surgery or Stereotactic Body Radiotherapy for Early Stage Lung Cancer: What is the Current Evidence?” 90
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 90
Lattice Radiation Therapy in clinical practice: A systematic review 89
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 89
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation 88
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 84
Guidelines on prostate carcinoma - AIRO, 2016 83
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 79
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study 79
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 78
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 76
How has prostate cancer radiotherapy changed in Italy between 2004 and 2011? An analysis of the national patterns-of-practice (pop) database by the uro-oncology study group of the italian society of radiotherapy and clinical oncology (airo) 76
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy 73
Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series 72
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 71
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study 71
Current radiotherapy techniques in NSCLC: challenges and potential solutions 71
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 70
Combining abiraterone and radiotherapy in prostate cancer patients who progressed during abiraterone therapy 69
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 68
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort 67
A Brief Report on the Role of SPECT/TC in the Optimization of Radiotherapy Treatment with Radical Intent for Unresectable Stage III NSCLC 65
Non-invasive approach to treat primary solid solitary pulmonary nodule: a narrative review by the radiation oncologist perspective 63
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study 63
Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach 63
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC 63
Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial 62
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study 62
Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings 61
Brain metastases from primary colorectal cancer: Is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO) 60
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 60
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 60
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 59
Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial 58
Radiosurgery Using Tomotherapy for Patients with Brain Oligo-metastasis: A Retrospective Analysis on Feasibility and Tolerance 58
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy 57
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 55
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE) 54
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach 54
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 51
Whole breast external beam radiotherapy in elderly patients affected by left-sided early breast cancer: a dosimetric comparison between two simple free-breathing techniques 50
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 48
Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer 48
Post-operative radiotherapy in N2 non-small cell lung cancer: A retrospective analysis of 175 patients 46
Oral ibandronate in metastatic bone breast cancer: The Florence University experience and a review of the literature 46
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 43
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 43
Radiotherapy Timing in 4,820 Patients With Breast Cancer: University of Florence Experience 43
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 41
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719) 41
Reirradiation in head and neck recurrent or second primary tumor: Efficacy, safety, and prognostic factors 41
Management of Stage II testicular seminoma over a period of 40 years 39
Hypofractionated radiation therapy in the management of locally advanced NSCLC: a narrative review of the literature on behalf of the Italian Association of Radiation Oncology (AIRO)—Lung Working Group 36
Radiotherapy timing in the treatment of limited-stage small cell lung cancer: The impact of thoracic and brain irradiation on survival 35
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 35
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy in metastatic breast cancer: A retrospective analysis 34
Radiation therapy in small cell lung cancer: a national Italian survey 33
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 29
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 29
Locally advanced NSCLC: overview of real-world pattern of recurrence in durvalumab era (LEOPARD trial) 14
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC Study 8
Totale 6.523
Categoria #
all - tutte 27.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.815


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021251 0 0 0 0 0 44 35 43 24 40 50 15
2021/2022405 59 25 15 15 14 25 27 31 39 31 93 31
2022/2023294 38 37 40 15 40 31 5 20 40 2 10 16
2023/2024257 18 13 24 31 21 12 22 40 8 15 15 38
2024/20251.715 30 2 17 62 158 133 46 78 171 314 355 349
2025/20263.092 505 406 702 791 607 81 0 0 0 0 0 0
Totale 6.523